This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kakiuchi, C. et al. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat. Genet. 35, 171–175 (2003).
Dow, G.S., Hudson, T.H., Vahey, M. & Koenig, M.L. The acute neurotoxicity of mefloquine may be mediated through a disruption of calcium homeostasis and ER function in vitro. Malar. J. 2 14 (2003).
Acknowledgements
Data and biomaterials of the NIMH pedigrees were collected in four projects that participated in the NIMH Bipolar Disorder Genetics Initiative. From 1991–1998, the Principal Investigators andCo-Investigators were as follows: J. Nurnberger, M. Miller and E. Bowman (Indiana University); T. Reich, A. Goate and J. Rice (Washington University); J.R. DePaulo Jr., S. Simpson and C. Stine (Johns Hopkins University); and E. Gershon, D. Kazuba and E. Maxwell (NIMH Intramural Research Program).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kakiuchi, C., Nanko, S., Kunugi, H. et al. Reply to "Lack of support for a genetic association of the XBP1 promoter polymorphism with bipolar disorder in probands of European origin". Nat Genet 36, 784–785 (2004). https://doi.org/10.1038/ng0804-784
Issue Date:
DOI: https://doi.org/10.1038/ng0804-784